NM-5072

N/A

Report date: 2025/01/22 10:49:22

Base Information

Drug NameNM-5072
Drug Alias NameNM5072NM-5072
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionComplement system proteins inhibitorsProperdin inhibitors
TargetsComplement system proteinsProperdin
Therapy Area/IndicationsHemoglobinuria, ParoxysmalAtypical Hemolytic Uremic SyndromeEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovelMed Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovelMed Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHemoglobinuria, ParoxysmalAtypical Hemolytic Uremic SyndromeEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A